---
title: "ENWEI PHARMACEUTICAL: Vice President completes a reduction of 0.0157%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254998096.md"
description: "ENWEI PHARMACEUTICAL announced that Vice President Chen Lei has reduced his holdings in the company by 16,200 shares through centralized bidding on August 26, 2025, at an average price of 38.65 yuan/share, representing a reduction ratio of 0.0157%; after the reduction, he holds 48,918 shares, accounting for 0.0475% of the total share capital"
datetime: "2025-08-28T11:50:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254998096.md)
  - [en](https://longbridge.com/en/news/254998096.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254998096.md)
---

# ENWEI PHARMACEUTICAL: Vice President completes a reduction of 0.0157%

ENWEI PHARMACEUTICAL announced that Vice President Chen Lei has reduced his holdings in the company by 16,200 shares through centralized bidding on August 26, 2025, at an average reduction price of 38.65 yuan/share, accounting for 0.0157% of the total shares; after the reduction, he holds 48,918 shares, representing 0.0475% of the total share capital

### Related Stocks

- [301331.CN](https://longbridge.com/en/quote/301331.CN.md)

## Related News & Research

- [ANALYSIS-China's shifting energy mix weakens pillar of global LNG growth](https://longbridge.com/en/news/294314731.md)
- [BUZZ-Sleep apnea pill developer Apnimed poised to jump in debut after upsized IPO](https://longbridge.com/en/news/294533308.md)
- [Ensurge Micropower secures NOK 20 million in convertible loan commitments at NOK 1 per share](https://longbridge.com/en/news/294529118.md)
- [IRB: Q1FY27 net profit jumped 51% YoY, supported by toll growth and InvIT gains](https://longbridge.com/en/news/294325669.md)
- [Atlantic Sapphire restructuring buyer Coral HoldCo launches mandatory tender offer at NOK 0.8 a share](https://longbridge.com/en/news/294393073.md)